2013
DOI: 10.1007/s12035-013-8539-y
|View full text |Cite
|
Sign up to set email alerts
|

Intracerebroventricular Streptozotocin Exacerbates Alzheimer-Like Changes of 3xTg-AD Mice

Abstract: Alzheimer’s disease (AD) involves several possible molecular mechanisms, including impaired brain insulin signaling and glucose metabolism. To investigate the role of metabolic insults in AD, we injected streptozotocin (STZ), a diabetogenic compound if used in the periphery, into the lateral ventricle of the 6-month old 3xTg-AD mice and studied the cognitive function as well as AD-like brain abnormalities, such as tau phosphorylation and Aβ accumulation, 3–6 weeks later. We found that STZ exacerbated impairmen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
45
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 77 publications
(51 citation statements)
references
References 70 publications
(86 reference statements)
5
45
1
Order By: Relevance
“…6a,b). Consistent with our previous studies1718, the levels of phosphorylated AKT (AKT pT308) were substantially upregulated in ICV-STZ rats (Fig. 6a,b).…”
Section: Resultssupporting
confidence: 92%
See 3 more Smart Citations
“…6a,b). Consistent with our previous studies1718, the levels of phosphorylated AKT (AKT pT308) were substantially upregulated in ICV-STZ rats (Fig. 6a,b).…”
Section: Resultssupporting
confidence: 92%
“…3a,b). Consistent with our previous studies18, the inhibitory phosphorylation of GSK-3 at Ser9 (GSK-3β) and Ser21 (GSK-3α) was dramatically upregulated in the hippocampus of ICV-STZ rats. Intranasal insulin reduced the phosphorylation level of GSK-3 in the hippocampus of ICV-STZ rats to that of the control rats (Fig.…”
Section: Resultssupporting
confidence: 91%
See 2 more Smart Citations
“…The STZ-treated animals develop IRBS which is associated with memory impairment, progressive cholinergic deficits, glucose hypometabolism, oxidative stress, and neurodegeneration that share many features in common with sAD in humans. STZ exacerbates AD-like changes which was similar to the 3xTg-AD mice pathophysiology such as processing of APP, glucose metabolism, insulin signaling, synaptic function, protein kinases, and apoptosis [2]. These alterations by STZ suggest that it disturbs multiple metabolic and cell signaling pathways in the brain.…”
Section: Introductionmentioning
confidence: 55%